MYD88 and colorectal carcinoma: Previous data suggest that the regulation of TLR8 receptors is associated with the immune response, but not tumor cancers [32,33,34]; TLR7/TLR8 have been reported to show potent antitumor activity significantly correlated with stage progression of CRC through the MyD88-dependent pathway [35,36].